{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:37:15Z","timestamp":1775021835161,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T00:00:00Z","timestamp":1574726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00428-019-02704-8","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T06:02:52Z","timestamp":1574748172000},"page":"667-681","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas"],"prefix":"10.1007","volume":"476","author":[{"given":"Santiago","family":"Montes-Moreno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilske","family":"Oschlies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Goodlad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snjezana","family":"Dotlic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Traverse-Glehen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith A.","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4094-1633","authenticated-orcid":false,"given":"Maria","family":"Calaminici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,26]]},"reference":[{"key":"2704_CR1","unstructured":"Swerdlow SH CE, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J (Eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (revised 4th edition). IARC: Lyon; 2017"},{"issue":"22","key":"2704_CR2","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2013-07-512830","volume":"122","author":"AM Perry","year":"2013","unstructured":"Perry AM, Warnke RA, Hu Q, Gaulard P, Copie-Bergman C, Alkan S, Wang HY, Cheng JX, Bacon CM, Delabie J, Ranheim E, Kucuk C, Hu X, Weisenburger DD, Jaffe ES, Chan WC (2013) Indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Blood. 122(22):3599\u20133606","journal-title":"Blood."},{"issue":"5","key":"2704_CR3","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1182\/blood-2010-08-302737","volume":"117","author":"A Mansoor","year":"2011","unstructured":"Mansoor A, Pittaluga S, Beck PL, Wilson WH, Ferry JA, Jaffe ES (2011) NK-cell enteropathy: a benign NK-cell lymphoproliferative disease mimicking intestinal lymphoma: clinicopathologic features and follow-up in a unique case series. Blood. 117(5):1447\u20131452","journal-title":"Blood."},{"issue":"25","key":"2704_CR4","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1182\/blood-2010-06-290650","volume":"116","author":"K Takeuchi","year":"2010","unstructured":"Takeuchi K, Yokoyama M, Ishizawa S, Terui Y, Nomura K, Marutsuka K, Nunomura M, Fukushima N, Yagyuu T, Nakamine H, Akiyama F, Hoshi K, Matsue K, Hatake K, Oshimi K (2010) Lymphomatoid gastropathy: a distinct clinicopathologic entity of self-limited pseudomalignant NK-cell proliferation. Blood. 116(25):5631\u20135637","journal-title":"Blood."},{"issue":"4","key":"2704_CR5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/gut.2009.195131","volume":"59","author":"A Rubio-Tapia","year":"2010","unstructured":"Rubio-Tapia A, Murray JA (2010) Classification and management of refractory coeliac disease. Gut. 59(4):547\u2013557","journal-title":"Gut."},{"issue":"1","key":"2704_CR6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2008.10.013","volume":"136","author":"A Rubio-Tapia","year":"2009","unstructured":"Rubio-Tapia A, Kelly DG, Lahr BD, Dogan A, Wu TT, Murray JA (2009) Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology. 136(1):99\u2013107 quiz 352-103","journal-title":"Gastroenterology."},{"issue":"1","key":"2704_CR7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","volume":"136","author":"G Malamut","year":"2009","unstructured":"Malamut G, Afchain P, Verkarre V, Lecomte T, Amiot A, Damotte D, Bouhnik Y, Colombel JF, Delchier JC, Allez M, Cosnes J, Lavergne-Slove A, Meresse B, Trinquart L, Macintyre E, Radford-Weiss I, Hermine O, Brousse N, Cerf-Bensussan N, Cellier C (2009) Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology. 136(1):81\u201390","journal-title":"Gastroenterology."},{"issue":"7","key":"2704_CR8","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s10875-014-0075-7","volume":"34","author":"RL van Wanrooij","year":"2014","unstructured":"van Wanrooij RL, M\u00fcller DM, Neefjes-Borst EA, Meijer J, Koudstaal LG, Heideman DA, Bontkes HJ, von Blomberg B, Bouma G, Mulder CJ (2014) Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease. J Clin Immunol 34(7):828\u2013835","journal-title":"J Clin Immunol"},{"issue":"3","key":"2704_CR9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/gut.51.3.372","volume":"51","author":"IN Farstad","year":"2002","unstructured":"Farstad IN, Johansen FE, Vlatkovic L, Jahnsen J, Scott H, Fausa O, Bj\u00f8rneklett A, Brandtzaeg P, Halstensen TS (2002) Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression. Gut. 51(3):372\u2013378","journal-title":"Gut."},{"issue":"8","key":"2704_CR10","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1136\/gutjnl-2018-317371","volume":"68","author":"M Cheminant","year":"2018","unstructured":"Cheminant M, Bruneau J, Malamut G et al (2018) NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study. Gut 68(8):1396\u20131405","journal-title":"Gut"},{"issue":"3","key":"2704_CR11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2016.07.018","volume":"45","author":"J Ettersperger","year":"2016","unstructured":"Ettersperger J, Montcuquet N, Malamut G, Guegan N, Lopez-Lastra S, Gayraud S, Reimann C, Vidal E, Cagnard N, Villarese P, Andre-Schmutz I, Gomes Domingues R, Godinho-Silva C, Veiga-Fernandes H, Lhermitte L, Asnafi V, Macintyre E, Cellier C, Beldjord K, di Santo JP, Cerf-Bensussan N, Meresse B (2016) Interleukin-15-dependent T-cell-like innate intraepithelial lymphocytes develop in the intestine and transform into lymphomas in celiac disease. Immunity. 45(3):610\u2013625","journal-title":"Immunity."},{"issue":"4","key":"2704_CR12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.molimm.2012.01.014","volume":"50","author":"GJ Tack","year":"2012","unstructured":"Tack GJ, van Wanrooij RL, Langerak AW, Tjon JM, von Blomberg B, Heideman DA, van Bergen J, Koning F, Bouma G, Mulder CJ, Schreurs MW (2012) Origin and immunophenotype of aberrant IEL in RCDII patients. Mol Immunol 50(4):262\u2013270","journal-title":"Mol Immunol"},{"issue":"5","key":"2704_CR13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","volume":"45","author":"G Malamut","year":"2013","unstructured":"Malamut G, Chandesris O, Verkarre V, Meresse B, Callens C, Macintyre E, Bouhnik Y, Gornet JM, Allez M, Jian R, Berger A, Ch\u00e2tellier G, Brousse N, Hermine O, Cerf-Bensussan N, Cellier C (2013) Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis 45(5):377\u2013384","journal-title":"Dig Liver Dis"},{"issue":"10","key":"2704_CR14","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/PAS.0b013e318222dfcd","volume":"35","author":"JK Chan","year":"2011","unstructured":"Chan JK, Chan AC, Cheuk W, Wan SK, Lee WK, Lui YH, Chan WK (2011) Type II enteropathy-associated T-cell lymphoma: a distinct aggressive lymphoma with frequent \u03b3\u03b4 T-cell receptor expression. Am J Surg Pathol 35(10):1557\u20131569","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2704_CR15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/modpathol.2011.45","volume":"24","author":"J Sun","year":"2011","unstructured":"Sun J, Lu Z, Yang D, Chen J (2011) Primary intestinal T-cell and NK-cell lymphomas: a clinicopathological and molecular study from China focused on type II enteropathy-associated T-cell lymphoma and primary intestinal NK-cell lymphoma. Mod Pathol 24(7):983\u2013992","journal-title":"Mod Pathol"},{"issue":"10","key":"2704_CR16","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1097\/PAS.0000000000000295","volume":"38","author":"SH Swerdlow","year":"2014","unstructured":"Swerdlow SH, Jaffe ES, Brousset P, Chan JK, de Leval L, Gaulard P, Harris NL, Pileri S, Weiss LM, International Lymphoma Study Group (2014) Cytotoxic T-cell and NK-cell lymphomas: current questions and controversies. Am J Surg Pathol 38(10):e60\u2013e71","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"2704_CR17","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/leu.2013.41","volume":"27","author":"SY Tan","year":"2013","unstructured":"Tan SY, Chuang SS, Tang T, Tan L, Ko YH, Chuah KL, Ng SB, Chng WJ, Gatter K, Loong F, Liu YH, Hosking P, Cheah PL, Teh BT, Tay K, Koh M, Lim ST (2013) Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8\u03b1\u03b1 phenotype. Leukemia. 27(8):1688\u20131696","journal-title":"Leukemia."},{"key":"2704_CR18","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1038\/ncomms12602","volume":"7","author":"A Roberti","year":"2016","unstructured":"Roberti A, Dobay MP, Bisig B et al (2016) Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations. Nat Commun 7:12602","journal-title":"Nat Commun"},{"key":"2704_CR19","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","volume":"6","author":"C Kucuk","year":"2015","unstructured":"Kucuk C, Jiang B, Hu X et al (2015) Activating mutations of STAT5B and STAT3 in lymphomas derived from gamma delta-T or NK cells. Nat Commun 6:6025","journal-title":"Nat Commun"},{"issue":"5","key":"2704_CR20","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1084\/jem.20160894","volume":"214","author":"AB Moffitt","year":"2017","unstructured":"Moffitt AB, Ondrejka SL, McKinney M, Rempel RE, Goodlad JR, Teh CH, Leppa S, Mannisto S, Kovanen PE, Tse E, Au-Yeung RKH, Kwong YL, Srivastava G, Iqbal J, Yu J, Naresh K, Villa D, Gascoyne RD, Said J, Czader MB, Chadburn A, Richards KL, Rajagopalan D, Davis NS, Smith EC, Palus BC, Tzeng TJ, Healy JA, Lugar PL, Datta J, Love C, Levy S, Dunson DB, Zhuang Y, Hsi ED, Dave SS (2017) Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2. J Exp Med 214(5):1371\u20131386","journal-title":"J Exp Med"},{"issue":"4","key":"2704_CR21","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/1097-0142(19940215)73:4<1286::AID-CNCR2820730425>3.0.CO;2-9","volume":"73","author":"F Carbonnel","year":"1994","unstructured":"Carbonnel F, Lavergne A, Messing B, Tsapis A, Berger R, Galian A, Nemeth J, Brouet JC, Rambaud JC (1994) Extensive small intestinal T-cell lymphoma of low-grade malignancy associated with a new chromosomal translocation. Cancer. 73(4):1286\u20131291","journal-title":"Cancer."},{"issue":"20","key":"2704_CR22","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood-2018-01-830968","volume":"131","author":"A Sharma","year":"2018","unstructured":"Sharma A, Oishi N, Boddicker RL, Hu G, Benson HK, Ketterling RP, Greipp PT, Knutson DL, Kloft-Nelson SM, He R, Eckloff BW, Jen J, Nair AA, Davila JI, Dasari S, Lazaridis KN, Bennani NN, Wu TT, Nowakowski GS, Murray JA, Feldman AL (2018) Recurrent STATJAK2 fusions in indolent T-cell lymphoproliferative dis-order of the gastrointestinal tract. Blood. 131(20):2262\u20132266","journal-title":"Blood."},{"key":"2704_CR23","doi-asserted-by":"crossref","unstructured":"Soderquist CR, Patel N, Murty VV et al (2019) Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract. Haematologica","DOI":"10.3324\/haematol.2019.230961"},{"issue":"1","key":"2704_CR24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/1066896918785985","volume":"27","author":"AM Perry","year":"2019","unstructured":"Perry AM, Bailey NG, Bonnett M, Jaffe ES, Chan WC (2019) Disease progression in a patient with indolent T-cell lymphoproliferative disease of the gastrointestinal tract. Int J Surg Pathol 27(1):102\u2013107","journal-title":"Int J Surg Pathol"},{"issue":"7","key":"2704_CR25","doi-asserted-by":"crossref","first-page":"e68343","DOI":"10.1371\/journal.pone.0068343","volume":"8","author":"E Margolskee","year":"2013","unstructured":"Margolskee E, Jobanputra V, Lewis SK, Alobeid B, Green PH, Bhagat G (2013) Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features. PLoS One 8(7):e68343","journal-title":"PLoS One"},{"issue":"1","key":"2704_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hon.2317","volume":"35","author":"R Matnani","year":"2017","unstructured":"Matnani R, Ganapathi KA, Lewis SK, Green PH, Alobeid B, Bhagat G (2017) Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update. Hematol Oncol 35(1):3\u201316","journal-title":"Hematol Oncol"},{"issue":"4","key":"2704_CR27","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00000478-200604000-00017","volume":"30","author":"F Vega","year":"2006","unstructured":"Vega F, Chang CC, Schwartz MR et al (2006) Atypical NK-cell proliferation of the gastrointestinal tract in a patient with antigliadin antibodies but not celiac disease. Am J Surg Pathol 30(4):539\u2013544","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"2704_CR28","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1182\/blood.2019001443","volume":"134","author":"W Xiao","year":"2019","unstructured":"Xiao W, Gupta GK, Yao J, Jang YJ, Xi L, Baik J, Sigler A, Kumar A, Moskowitz AJ, Arcila ME, Raffeld M, Pittaluga S, Dogan A, Jaffe ES (2019) Recurrent somatic JAK3 mutations in NK-cell enteropathy. Blood. 134(12):986\u2013991","journal-title":"Blood."},{"issue":"7","key":"2704_CR29","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ni1353","volume":"7","author":"A Caraux","year":"2006","unstructured":"Caraux A, Lu Q, Fernandez N, Riou S, di Santo JP, Raulet DH, Lemke G, Roth C (2006) Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases. Nat Immunol 7(7):747\u2013754","journal-title":"Nat Immunol"},{"issue":"7493","key":"2704_CR30","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nature12998","volume":"507","author":"M Paolino","year":"2014","unstructured":"Paolino M, Choidas A, Wallner S, Pranjic B, Uribesalgo I, Loeser S, Jamieson AM, Langdon WY, Ikeda F, Fededa JP, Cronin SJ, Nitsch R, Schultz-Fademrecht C, Eickhoff J, Menninger S, Unger A, Torka R, Gruber T, Hinterleitner R, Baier G, Wolf D, Ullrich A, Klebl BM, Penninger JM (2014) The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells. Nature. 507(7493):508\u2013512","journal-title":"Nature."},{"issue":"1","key":"2704_CR31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/modpathol.2012.127","volume":"26","author":"K Takata","year":"2013","unstructured":"Takata K, Sato Y, Nakamura N, Tokunaka M, Miki Y, Yukie Kikuti Y, Igarashi K, Ito E, Harigae H, Kato S, Hayashi E, Oka T, Hoshii Y, Tari A, Okada H, al-Kader LA, Maeda Y, Tanimoto M, Kinoshita T, Yoshino T (2013) Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics. Mod Pathol 26(1):22\u201331","journal-title":"Mod Pathol"},{"issue":"16","key":"2704_CR32","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2018-03-837252","volume":"132","author":"JC Hellmuth","year":"2018","unstructured":"Hellmuth JC, Louissaint A, Szczepanowski M et al (2018) Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles. Blood. 132(16):1695\u20131702","journal-title":"Blood."},{"issue":"9","key":"2704_CR33","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.humpath.2013.02.004","volume":"44","author":"P Adam","year":"2013","unstructured":"Adam P, Baumann R, Schmidt J, Bettio S, Weisel K, Bonzheim I, Fend F, Quintanilla-Mart\u00ednez L (2013) The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-\u201cnegative\u201d grade 1\/2 follicular lymphomas. Hum Pathol 44(9):1817\u20131826","journal-title":"Hum Pathol"},{"issue":"3","key":"2704_CR34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3324\/haematol.2013.094474","volume":"99","author":"E Mamessier","year":"2014","unstructured":"Mamessier E, Song JY, Eberle FC, Pack S, Drevet C, Chetaille B, Abdullaev Z, Adela\u00efde J, Birnbaum D, Chaffanet M, Pittaluga S, Roulland S, Chott A, Jaffe ES, Nadel B (2014) Early lesions of follicular lymphoma: a genetic perspective. Haematologica. 99(3):481\u2013488","journal-title":"Haematologica."},{"issue":"5","key":"2704_CR35","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/cas.12392","volume":"105","author":"K Takata","year":"2014","unstructured":"Takata K, Tanino M, Ennishi D, Tari A, Sato Y, Okada H, Maeda Y, Goto N, Araki H, Harada M, Ando M, Iwamuro M, Tanimoto M, Yamamoto K, Gascoyne RD, Yoshino T (2014) Duodenal follicular lymphoma: comprehensive gene expression analysis with insights into pathogenesis. Cancer Sci 105(5):608\u2013615","journal-title":"Cancer Sci"},{"issue":"1","key":"2704_CR36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/10428194.2012.698390","volume":"54","author":"AP Kiess","year":"2013","unstructured":"Kiess AP, Yahalom J (2013) Primary follicular lymphoma of the gastrointestinal tract: effect of stage, symptoms and treatment choice on outcome. Leuk Lymphoma 54(1):177\u2013180","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"2704_CR37","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1349-7006.2011.01980.x","volume":"102","author":"K Takata","year":"2011","unstructured":"Takata K, Okada H, Ohmiya N, Nakamura S, Kitadai Y, Tari A, Akamatsu T, Kawai H, Tanaka S, Araki H, Yoshida T, Okumura H, Nishisaki H, Sagawa T, Watanabe N, Arima N, Takatsu N, Nakamura M, Yanai S, Kaya H, Morito T, Sato Y, Moriwaki H, Sakamoto C, Niwa Y, Goto H, Chiba T, Matsumoto T, Ennishi D, Kinoshita T, Yoshino T (2011) Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity: a multicenter, retrospective analysis in Japan. Cancer Sci 102(8):1532\u20131536","journal-title":"Cancer Sci"},{"issue":"8","key":"2704_CR38","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/jgh.14100","volume":"33","author":"A Tari","year":"2018","unstructured":"Tari A, Kitadai Y, Mouri R, Takigawa H, Asaoku H, Mihara K, Takata K, Fujihara M, Yoshino T, Koga T, Fujimori S, Tanaka S, Chayama K (2018) Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma. J Gastroenterol Hepatol 33(8):1461\u20131468","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"2704_CR39","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1200\/JCO.2010.32.9193","volume":"29","author":"AI Schmatz","year":"2011","unstructured":"Schmatz AI, Streubel B, Kretschmer-Chott E, P\u00fcsp\u00f6k A, J\u00e4ger U, Mannhalter C, Tiemann M, Ott G, Fischbach W, Herzog P, Seitz G, Stolte M, Raderer M, Chott A (2011) Primary follicular lymphoma of the duodenum is a distinct mucosal\/submucosal variant of follicular lymphoma: a retrospective study of 63 cases. J Clin Oncol 29(11):1445\u20131451","journal-title":"J Clin Oncol"},{"issue":"8","key":"2704_CR40","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/jjco\/hyn069","volume":"38","author":"K Sentani","year":"2008","unstructured":"Sentani K, Maeshima AM, Nomoto J, Maruyama D, Kim SW, Watanabe T, Kobayashi Y, Tobinai K, Matsuno Y (2008) Follicular lymphoma of the duodenum: a clinicopathologic analysis of 26 cases. Jpn J Clin Oncol 38(8):547\u2013552","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"2704_CR41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12328-016-0697-9","volume":"10","author":"H Kitabatake","year":"2017","unstructured":"Kitabatake H, Nagaya T, Tanaka N, Ota H, Sano K, Asano N, Suga T, Nakamura Y, Akamatsu T, Tanaka E (2017) Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up. Clin J Gastroenterol 10(1):79\u201385","journal-title":"Clin J Gastroenterol"},{"issue":"10","key":"2704_CR42","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/pin.12197","volume":"64","author":"T Miyata-Takata","year":"2014","unstructured":"Miyata-Takata T, Takata K, Sato Y, Taniguchi K, Takahashi Y, Ohara N, Yoshino T (2014) A case of diffuse large B-cell lymphoma transformed from primary duodenal follicular lymphoma. Pathol Int 64(10):527\u2013532","journal-title":"Pathol Int"},{"issue":"8","key":"2704_CR43","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","volume":"121","author":"I Salaverria","year":"2013","unstructured":"Salaverria I, Royo C, Carvajal-Cuenca A et al (2013) CCND2 rearrangements are the most frequent genetic events in cyclin D1(\u2212) mantle cell lymphoma. Blood. 121(8):1394\u20131402","journal-title":"Blood."},{"issue":"13","key":"2704_CR44","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","volume":"106","author":"K Fu","year":"2005","unstructured":"Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, de Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, Dave BJ, Sanger WG, Smith LM, Rimsza L, Braziel RM, M\u00fcller-Hermelink HK, Campo E, Gascoyne RD, Staudt LM, Chan WC, Lymphoma\/Leukemia Molecular Profiling Project (2005) Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood. 106(13):4315\u20134321","journal-title":"Blood."},{"issue":"9","key":"2704_CR45","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2018-07-862151","volume":"133","author":"D Mart\u00edn-Garcia","year":"2019","unstructured":"Mart\u00edn-Garcia D, Navarro A, Vald\u00e9s-Mas R, Clot G, Guti\u00e9rrez-Abril J, Prieto M, Ribera-Cortada I, Woroniecka R, Rymkiewicz G, Bens S, de Leval L, Rosenwald A, Ferry JA, Hsi ED, Fu K, Delabie J, Weisenburger D, de Jong D, Climent F, O\u2019Connor SJ, Swerdlow SH, Torrents D, Beltran S, Espinet B, Gonz\u00e1lez-Farr\u00e9 B, Veloza L, Costa D, Matutes E, Siebert R, Ott G, Quintanilla-Martinez L, Jaffe ES, L\u00f3pez-Ot\u00edn C, Salaverria I, Puente XS, Campo E, Be\u00e0 S (2019) CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1 - mantle cell lymphoma. Blood. 133(9):940\u2013951","journal-title":"Blood."},{"issue":"1","key":"2704_CR46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9440(10)65558-7","volume":"153","author":"L Quintanilla-Martinez","year":"1998","unstructured":"Quintanilla-Martinez L, Thieblemont C, Fend F, Kumar S, Pinyol M, Campo E, Jaffe ES, Raffeld M (1998) Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor. Am J Pathol 153(1):175\u2013182","journal-title":"Am J Pathol"},{"issue":"4","key":"2704_CR47","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","volume":"70","author":"V Fernandez","year":"2010","unstructured":"Fernandez V, Salamero O, Espinet B et al (2010) Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 70(4):1408\u20131418","journal-title":"Cancer Res"},{"issue":"8","key":"2704_CR48","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","volume":"96","author":"SL Ondrejka","year":"2011","unstructured":"Ondrejka SL, Lai R, Smith SD, Hsi ED (2011) Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis. Haematologica. 96(8):1121\u20131127","journal-title":"Haematologica."},{"issue":"1","key":"2704_CR49","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","volume":"118","author":"I Salaverria","year":"2011","unstructured":"Salaverria I, Philipp C, Oschlies I, Kohler CW, Kreuz M, Szczepanowski M, Burkhardt B, Trautmann H, Gesk S, Andrusiewicz M, Berger H, Fey M, Harder L, Hasenclever D, Hummel M, Loeffler M, Mahn F, Martin-Guerrero I, Pellissery S, Pott C, Pfreundschuh M, Reiter A, Richter J, Rosolowski M, Schwaenen C, Stein H, Tr\u00fcmper L, Wessendorf S, Spang R, K\u00fcppers R, Klapper W, Siebert R, Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe, German High-Grade Lymphoma Study Group, Berlin-Frankfurt-M\u00fcnster-NHL trial group (2011) Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults. Blood. 118(1):139\u2013147","journal-title":"Blood."},{"issue":"3","key":"2704_CR50","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/PAS.0b013e31826b9b57","volume":"37","author":"Q Liu","year":"2013","unstructured":"Liu Q, Salaverria I, Pittaluga S, Jegalian AG, Xi L, Siebert R, Raffeld M, Hewitt SM, Jaffe ES (2013) Follicular lymphomas in children and young adults: a comparison of the pediatric variant with usual follicular lymphoma. Am J Surg Pathol 37(3):333\u2013343","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"2704_CR51","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1093\/annonc\/mds150","volume":"23","author":"L de Leval","year":"2012","unstructured":"de Leval L, Bonnet C, Copie-Bergman C, Seidel L, Baia M, Bri\u00e8re J, Molina TJ, Fabiani B, Petrella T, Bosq J, Gisselbrecht C, Siebert R, Tilly H, Haioun C, Fillet G, Gaulard P (2012) Diffuse large B-cell lymphoma of Waldeyer\u2019s ring has distinct clinicopathologic features: a GELA study. Ann Oncol 23(12):3143\u20133151","journal-title":"Ann Oncol"},{"issue":"7","key":"2704_CR52","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/ijc.30838","volume":"141","author":"T Zenz","year":"2017","unstructured":"Zenz T, Kreuz M, Fuge M, Klapper W, Horn H, Staiger AM, Winter D, Helfrich H, Huellein J, Hansmann ML, Stein H, Feller A, M\u00f6ller P, Schmitz N, Tr\u00fcmper L, Loeffler M, Siebert R, Rosenwald A, Ott G, Pfreundschuh M, Stilgenbauer S, German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) (2017) TP53 mutation and survival in aggressive B cell lymphoma. Int J Cancer 141(7):1381\u20131388","journal-title":"Int J Cancer"},{"issue":"19","key":"2704_CR53","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1182\/blood-2012-05-433334","volume":"120","author":"ZY Xu-Monette","year":"2012","unstructured":"Xu-Monette ZY, Wu L, Visco C, Tai YC, Tzankov A, Liu WM, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Zhao XF, Choi WW, Zhao X, van Krieken J, Huang Q, Huh J, Ai W, Ponzoni M, Ferreri AJ, Zhou F, Kahl BS, Winter JN, Xu W, Li J, Go RS, Li Y, Piris MA, M\u00f8ller MB, Miranda RN, Abruzzo LV, Medeiros LJ, Young KH (2012) Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study. Blood. 120(19):3986\u20133996","journal-title":"Blood."},{"issue":"3","key":"2704_CR54","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cjp2.10","volume":"1","author":"A Clipson","year":"2015","unstructured":"Clipson A, Barrans S, Zeng N, Crouch S, Grigoropoulos NF, Liu H, Kocialkowski S, Wang M, Huang Y, Worrillow L, Goodlad J, Buxton J, Neat M, Fields P, Wilkins B, Grant JW, Wright P, Ei-Daly H, Follows GA, Roman E, Watkins AJ, Johnson PW, Jack A, du MQ (2015) The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit. J Pathol Clin Res 1(3):125\u2013133","journal-title":"J Pathol Clin Res"}],"updated-by":[{"DOI":"10.1007\/s00428-020-02772-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T00:00:00Z","timestamp":1582243200000}}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02704-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-019-02704-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-019-02704-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:45:51Z","timestamp":1606265151000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-019-02704-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,26]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["2704"],"URL":"https:\/\/doi.org\/10.1007\/s00428-019-02704-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00428-020-02772-1","asserted-by":"object"}]},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,26]]},"assertion":[{"value":"11 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2020","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This erratum is meant to address the error in which the names of one of the authors of the manuscript, was incorrect. Author assumes full responsibility for this error.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}